285 related articles for article (PubMed ID: 2310427)
1. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer.
Channon KM; Clegg RJ; Bhatnagar D; Ishola M; Arrol S; Durrington PN
Atherosclerosis; 1990 Jan; 80(3):217-26. PubMed ID: 2310427
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma.
Yen FT; Deckelbaum RJ; Mann CJ; Marcel YL; Milne RW; Tall AR
J Clin Invest; 1989 Jun; 83(6):2018-24. PubMed ID: 2723070
[TBL] [Abstract][Full Text] [Related]
3. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
Chung BH; Segrest JP; Franklin F
Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
[TBL] [Abstract][Full Text] [Related]
4. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
Dullaart RP; Gansevoort RT; Dikkeschei BD; de Zeeuw D; de Jong PE; Van Tol A
Kidney Int; 1993 Jul; 44(1):91-7. PubMed ID: 8355471
[TBL] [Abstract][Full Text] [Related]
5. Postprandial chylomicrons: potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP.
Chung BH; Liang P; Doran S; Cho BH; Franklin F
J Lipid Res; 2004 Jul; 45(7):1242-55. PubMed ID: 15102891
[TBL] [Abstract][Full Text] [Related]
6. Low plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone deficient and acromegalic men: role in altered high density lipoproteins.
Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
Atherosclerosis; 2000 Dec; 153(2):491-8. PubMed ID: 11164439
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose.
Chang CK; Tso TK; Snook JT; Huang YS; Lozano RA; Zipf WB
Acta Diabetol; 2001; 38(1):37-42. PubMed ID: 11487175
[TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
J Lipid Res; 2002 Oct; 43(10):1652-60. PubMed ID: 12364549
[TBL] [Abstract][Full Text] [Related]
9. Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy.
Beentjes JA; van Tol A; Sluiter WJ; Dullaart RP
Scand J Clin Lab Invest; 2000 May; 60(3):189-98. PubMed ID: 10885490
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma.
Murakami T; Michelagnoli S; Longhi R; Gianfranceschi G; Pazzucconi F; Calabresi L; Sirtori CR; Franceschini G
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1819-28. PubMed ID: 7583561
[TBL] [Abstract][Full Text] [Related]
11. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
Riemens S; van Tol A; Sluiter W; Dullaart R
Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
[TBL] [Abstract][Full Text] [Related]
13. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
[TBL] [Abstract][Full Text] [Related]
14. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
[TBL] [Abstract][Full Text] [Related]
15. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
Serdyuk AP; Morton RE
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
[TBL] [Abstract][Full Text] [Related]
16. Transfer and equilibration of LCAT-generated cholesteryl esters in human lipoproteins.
Rose HG
Scand J Clin Lab Invest Suppl; 1978; 150():91-7. PubMed ID: 218281
[TBL] [Abstract][Full Text] [Related]
17. Plasma cholesteryl ester synthesis, cholesteryl ester transfer protein concentration and activity in hypercholesterolemic women: effects of the degree of saturation of dietary fatty acids in the fasting and postprandial states.
Lottenberg AM; Nunes VS; Lottenberg SA; Shimabukuro AF; Carrilho AJ; Malagutti S; Nakandakare ER; McPherson R; Quintão EC
Atherosclerosis; 1996 Oct; 126(2):265-75. PubMed ID: 8902152
[TBL] [Abstract][Full Text] [Related]
18. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
[TBL] [Abstract][Full Text] [Related]
19. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
[TBL] [Abstract][Full Text] [Related]
20. Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes.
Chung BH; Franklin F; Cho BH; Segrest JP; Hart K; Darnell BE
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1217-30. PubMed ID: 9714128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
